MOMENTA PHARMACEUTICALS
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans. This results in a diversified product pipeline of complex generic, follow-on biologic and novel drugs. The Company's two most advanced complex generic product candidates target marketed products, which were originally approved by t... he United States Food and Drug Administration as New Drug Applications. M-Enoxaparin is designed to be a generic version of Lovenox (enoxaparin sodium injection), a low-molecular weight heparin used to prevent and treat deep vein thrombosis. Its second major generic product candidate is M356, a generic version of Copaxone (glatiramer acetate injection), a drug that is indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis.
MOMENTA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.momentapharma.com
Total Employee:
501+
Status:
Active
Contact:
(617)621-0431
Email Addresses:
[email protected]
Total Funding:
39.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Domain Not Resolving Amazon
Similar Organizations
Entos Pharmaceuticals
Entos Pharmaceuticals is a healthcare biotechnology company that develops nucleic acid therapies.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-12-05 | Virdante Pharmaceuticals | Virdante Pharmaceuticals acquired by Momenta Pharmaceuticals | 51.5 M USD |
| 2007-05-10 | Parivid | Parivid acquired by Momenta Pharmaceuticals | N/A |
Investors List
Atlas Venture
Atlas Venture investment in Series C - Momenta Pharmaceuticals
Mithra Ventures
Mithra Ventures investment in Series C - Momenta Pharmaceuticals
Cardinal Partners
Cardinal Partners investment in Series C - Momenta Pharmaceuticals
MVM Life Science Partners
MVM Life Science Partners investment in Series C - Momenta Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series C - Momenta Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series B - Momenta Pharmaceuticals
Atlas Venture
Atlas Venture investment in Series B - Momenta Pharmaceuticals
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Momenta Pharmaceuticals
Cardinal Partners
Cardinal Partners investment in Series B - Momenta Pharmaceuticals
Official Site Inspections
http://www.momentapharma.com
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 16.182.41.5
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Momenta Pharmaceuticals"
Momenta Pharmaceuticals, Inc. - Home
Momenta was acquired by Johnson & Johnson. Please visit us at https://www.janssen.com/us/ We at Janssen will be happy to answer any general product-related questions. However, we …See details»
Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., …
NEW BRUNSWICK, N.J., August 19, 2020 – Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), …See details»
Johnson & Johnson Completes Acquisition of Momenta …
Oct 1, 2020 · Momenta now operates as a wholly-owned subsidiary of Johnson & Johnson. In connection with the merger, shares of Momenta that were not tendered in the tender offer …See details»
Momenta Pharmaceuticals - Crunchbase Company Profile & Funding
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules.See details»
Momenta Pharmaceuticals Company Profile | Management and
Momenta Pharmaceuticals is a biotechnology company focusing on the detailed structural analysis of complex drugs. Momenta is applying its technology to the development of generic …See details»
Overview, News & Similar companies - ZoomInfo.com
Oct 1, 2020 · Momenta Pharmaceuticals contact info: Phone number: (617) 491-9700 Website: www.momentapharma.com What does Momenta Pharmaceuticals do? Momenta …See details»
Momenta Pharmaceuticals - PitchBook
Momenta is a biotechnology company focused on the characterization and development of innovative drugs in autoimmune diseases. Its legacy business includes complex generic …See details»
Momenta Pharmaceuticals - LinkedIn
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our …See details»
Momenta Pharmaceuticals - Craft
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the characterization and process engineering of complex molecules. These complex molecules include proteins, …See details»
Momenta Pharmaceuticals Company Profile: , Investments, Contact ...
Our scientific foundation is based on a deep understanding of immune biology and disease analytics. This work, together with our protein engineering and antibody design expertise has …See details»
Organization: Momenta Pharmaceuticals LEI …
Momenta Pharmaceuticals. Information about the issuer. News and credit ratings. (LEI 529900BB2VMRCT4YQ588). Tables with accounting and financial reporting.See details»
Momenta Pharmaceuticals CEO and Key Executive Team
Momenta Pharmaceuticals's key executives include Santiago Arroyo and 5 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on …See details»
Momenta Pharmaceuticals: Contact Details and Business Profile
Momenta is a biotechnology company with a validated innovative scientific platform focused on discovering and developing novel therapeutics to treat rare, immune-mediated diseases. Our …See details»
Momenta Pharmaceuticals Company Overview, Contact Details
Momenta Pharmaceuticals, Inc., a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases has entered …See details»
Momenta Pharmaceuticals Completes Strategic Review to
CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced the completion of its strategic review aimed at reducing …See details»
Momenta Pharmaceuticals Inc - Company Profile - GlobalData
Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s …See details»
Articles about Momenta Pharmaceuticals, Inc. - BioSpace
May 25, 2022 · Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune …See details»
Momenta Pharmaceuticals Announces Appointment of Craig A.
CAMBRIDGE, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company specializing in the characterization and engineering of …See details»
Momenta Pharmaceuticals - CB Insights
Momenta Pharmaceuticals has 8 executives. Momenta Pharmaceuticals's current Chief Executive Officer is Alan Crane. You're one click away from the most comprehensive, unmatched analyst …See details»
Momenta Pharmaceuticals Announces Executive Promotions
CAMBRIDGE, Mass., April 12 /PRNewswire-FirstCall/ -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company developing drugs based on its proprietary sugar sequencing …See details»